STRS Ohio’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,900
Closed -$378K 2186
2019
Q3
$378K Sell
3,900
-100
-3% -$10K ﹤0.01% 1436
2019
Q2
$409K Buy
+4,000
New +$432K ﹤0.01% 1417
2018
Q3
Sell
-1,200
Closed -$82.1K 2225
2018
Q2
$99K Buy
+1,200
New +$92.6K ﹤0.01% 1864
2017
Q4
Sell
-1,000
Closed -$89K 1967
2017
Q3
$89K Buy
+1,000
New +$75.9K ﹤0.01% 1674
2016
Q1
Sell
-6,200
Closed -$196K 1952
2015
Q4
$280K Sell
6,200
-5,600
-47% -$294K ﹤0.01% 1447
2015
Q3
$492K Hold
11,800
﹤0.01% 1284
2015
Q2
$711K Buy
11,800
+9,100
+337% +$602K ﹤0.01% 1139
2015
Q1
$209K Buy
+2,700
New +$155K ﹤0.01% 1457

STRS Ohio's ONCE Position: Q4 2019 in Review

STRS Ohio sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 3,900 shares — an estimated $378K sold.

STRS Ohio first reported a position in ONCE in Q1 2015 and held it in 8 quarters. The position peaked at $711K in Q2 2015. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • STRS Ohio reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • STRS Ohio sold 3,900 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $378K.
  • STRS Ohio first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 8 quarters.
  • STRS Ohio's Spark Therapeutics, Inc. Common Stock position peaked at $711K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on STRS Ohio's 13F filing for Q4 2019, filed 24 Jan 2020.